ArticleWorld journal of gastroenterology2024

Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease.

Maurizio Soresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.